Position in ARGX
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$31,544
New position
Shares Held
34
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#407
of 504 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026EASTERN BANK holds $42,864,501 across 26 Biotechnology names. ARGX ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
694,925 | $38,964,444 | |
| 2 | VERA |
Vera Therapeutics, Inc.
|
56,050 | $2,418,557 | |
| 3 | MRNA |
Moderna, Inc.
|
14,578 | $1,020,896 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
305 | $151,502 | |
| 5 | NUVL |
Nuvalent, Inc.
|
604 | $74,594 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57 | $35,541 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
65 | $34,901 | |
| 8 | ARGX |
Argenx SE
This page
|
34 | $31,544 |
All Filings in ARGX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,544 | 34 | Shares | Defined | 2026-07-01 | |
| No filing history on record for this holder in this stock. | ||||||